Biotechnology This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 12.

Citizen microbiome
Nature Biotechnology 31, 90 (2013). doi:10.1038/nbt0213-90a Author: Moheb Costandi
Source: Nature Biotechnology - February 7, 2013 Category: Biotechnology Authors: Moheb Costandi Tags: News Source Type: research

First novel anti-tuberculosis drug in 40 years
Nature Biotechnology 31, 89 (2013). doi:10.1038/nbt0213-89 Author: Randy Osborne
Source: Nature Biotechnology - February 7, 2013 Category: Biotechnology Authors: Randy Osborne Tags: News Source Type: research

Chinese investors tap US biotechs
Nature Biotechnology 31, 88 (2013). doi:10.1038/nbt0213-88 Author: Hepeng Jia
Source: Nature Biotechnology - February 7, 2013 Category: Biotechnology Authors: Hepeng Jia Tags: News Source Type: research

Amgen punts on deCODE's genetics know-how
Nature Biotechnology 31, 87 (2013). doi:10.1038/nbt0213-87 Author: Cormac Sheridan
Source: Nature Biotechnology - February 7, 2013 Category: Biotechnology Authors: Cormac Sheridan Tags: News Source Type: research

Dishing out cancer treatment
Nature Biotechnology 31, 85 (2013). doi:10.1038/nbt.2516 Despite their limitations, in vitro assays are a simple means for assessing the drug sensitivity of a patient's cancer. After consulting experts in the community, we think such assays deserve a second look.
Source: Nature Biotechnology - February 7, 2013 Category: Biotechnology Tags: Editorial Source Type: research

NC voters feeling down in HPU Poll
North Carolina voters have a generally negative outlook on the economy and politics, according to the latest High Point University Poll. That poll, taken at the end of January, found that 37 percent of respondents feel their family is worse off financially than they were a year ago, while 32 percent felt they were better off. In March 2012, only 15 percent of respondents said they believed their family was worse off financially. More than half of the respondents, 52 percent, say they oppose the…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: Matt Evans Source Type: research

Cincinnati Children’s 3rd best pediatric hospital in U.S.
Cincinnati Children’s Hospital Medical Center is the third best pediatric hospital in the United States, according to Parents magazine. Cincinnati Children’s ranked among the top three hospitals for all six areas of pediatric subspecialty care in the publication’s 10 Best Children’s Hospitals survey. For pulmonary care, the institution was No. 1. The hospitals were ranked by Parents editors, with input from a team of medical advisers, based on responses to questions on areas such as survival…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: James Ritchie Source Type: research

Aqua Pharmaceuticals CEO Goodling retires
Aqua Pharmaceuticals co-founder Jay Gooding is retiring as CEO of the 8-year-old specialty pharmaceuticals company early next month. Fellow co-founder Craig Ballaron, Aqua’s president, will continue in his president’s role and take on the CEO position. Gooding decided to retire to spend more time with his family and focus on pursuing other passions, including his charity work. “Without Jay, Aqua wouldn’t exist today,” said Ballaron, in a statement. “He has been a great business partner,…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: John George Source Type: research

P&G, TriHealth among best organizations for female executives
Procter & Gamble Co. and TriHealth are among the best organizations in the country for female executives, according to a new ranking. P&G, the Cincinnati-based consumer-goods giant, placed seventh on the National Association for Female Executives’ 2013 companies list. TriHealth was No. 7 on the nonprofits list. Companies were rated on areas such as board diversity – P&G (NYSE: PG) has five female board members – and flexible work arrangements. The recognition is “a noteworthy milestone…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: James Ritchie Source Type: research

CHOP consolidating some community sites into new Karabots center
The Children’s Hospital of Philadelphia is officially opening its $27 million Karabots Primary Care Center Wednesday. The 52,000-square-foot facility at 48th and Market streets in West Philadelphia was created to provide pediatric care and community programs to children and families in the surrounding neighborhoods. The two-story building, built on a four-acre site, contains 56 examination rooms; rooms dedicated to radiology, hearing and vision testing; and a phlebotomy laboratory. The Karabots…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: John George Source Type: research

Hospitals’ take on Pa. Gov. Corbett’s budget proposal
Philadelphia-area hospitals found some things to like, and one major area of concern, in the budget proposal put forth by Pa. Gov. Tom Corbett Tuesday. “We were pleased to see that the governor’s budget plan for 2013-2014 preserves inpatient hospital payments at current-year levels, including supplemental payments for critical access hospitals, trauma centers, medical education, obstetrics and neonatal services, and other key hospitals programs serving the state’s most vulnerable citizens,”…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: John George Source Type: research

Houston's PBK to assist with billion-dollar hospital in Turkey
Houston-based PBK Architects Inc. will partner with a Turkish construction and development company for a 12.1 million-square-foot, $1.5 billion medical campus in Ankara, Turkey. The medical campus will consist of eight hospital towers, which will be connected to a medical core, said Greg Hughes, PBK's director of health care. The campus will consist of women's, children's, cardiovascular, cancer and orthopedic hospitals and will have 3,662 beds total. Hughes said PBK was approached to do the design-review…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: Bayan Raji Source Type: research

Democrats propose BadgerCare plan
Two Wisconsin Democratic legislators announced their own plan that they said would close a gap in the state’s BadgerCare program. Rep. Jon Richards (D-Milwaukee) and state Sen. Jon Erpenbach (D-Middleton) said Tuesday their “Strengthen BadgerCare Act” capitalizes on financing available through the federal Affordable Care Act to provide coverage to Wisconsinites not covered by BadgerCare. The nonpartisan Legislative Fiscal Bureau estimated the Richards-Erpenbach plan could potentially extend…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: Rich Kirchen Source Type: research

Levine Cancer Institute teams with UNC Charlotte on research
The Levine Cancer Institute and UNC Charlotte will offer at least $400,000 in grants for pancreatic cancer research over the next two years. Together, they’ve created an initiative, called the Charlotte Pancreatic Cancer Project, to foster collaboration between physicians and scientists at both institutions. “It’s a very challenging disease — we’re not making the progress we need to,” says Dr. Derek Raghavan, president of the cancer institute, which is part of Charlotte-based Carolinas…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: Jennifer Thomas Source Type: research

Insurance brokers to fight for state health exchange
Health insurance agents and brokers plan to lobby against legislation that would keep the state from establishing a health insurance exchange. The exchange, a product of the Patient Protection and Affordable Care Act, is to serve as a marketplace for those seeking insurance policies. The legislation prohibiting the state from operating an exchange unless authorized by the General Assembly was introduced by Kentucky Sen. Julie Denton, R-Louisville, in January. It undermines an executive order issued…
Source: bizjournals.com Health Care:Biotechnology headlines - February 6, 2013 Category: Biotechnology Authors: David A. Mann Source Type: research

Biogen to buy Elan’s stake in MS drug
US biotechnology company will pay $3.25bn in cash and will have full control of the treatment, Tysabri, which it developed with Elan
Source: FT.com - Drugs and Healthcare - February 6, 2013 Category: Pharmaceuticals Source Type: news

Elan / Biogen: where are the drugs?
The Ireland-based biotechnology group has been looking for a strategic direction to take for several years. Now that it has sold its main drug, it needs a new plan soon
Source: FT.com - Drugs and Healthcare - February 6, 2013 Category: Pharmaceuticals Source Type: news

NSF Health Science-Consulting, Auditing, Testing, Training and Regulatory Support
NSF International Health Sciences Division provides an extensive range of quality services to the pharmaceutical, biotech and medical device industries.
Source: Pharmaceutical Technology - February 6, 2013 Category: Pharmaceuticals Source Type: news

Sophisticated Modeling And Biotechnology Used To Weaken Cells By Fouling Their Metabolic Machinery In War Against Antibiotic-Resistant Bacteria
A team of scientists just won a battle in the war against antibiotic-resistant "superbugs" -- and only time will tell if their feat is akin to the bacterial "Battle of Gettysburg" that turns the tide toward victory. They won this particular battle, or at least gained some critical intelligence, not by designing a new antibiotic, but by interfering with the metabolism of the bacterial "bugs" - E. coli in this case - and rendering them weaker in the face of existing antibiotics, as reported in Nature Biotechnology...
Source: Health News from Medical News Today - February 6, 2013 Category: Consumer Health News Tags: MRSA / Drug Resistance Source Type: news

Feasibility of anaerobic digested corn stover as biosorbent for heavy metal.
Abstract Anaerobic digested (AD) corn stover collected from a lab-scale reactor was used as bioadsorbent to remove the heavy metal in aqueous solution. Effects of contact time and initial heavy metal concentrations on the removal process of Cu(2+) and Cd(2+) were investigated. The maximum adsorption capacities of AD corn stover obtained from Langmuir isotherm models were 83.3 and 50.0mg/g for Cu(2+) and Cd(2+), respectively. Fourier transform infrared spectroscopy (FTIR) was also used to investigate the surface characteristic of raw and heavy metal loaded AD corn stover. PMID: 23428799 [PubMed - as supplied by publisher]
Source: Bioresource Technology - February 6, 2013 Category: Biotechnology Authors: Wang J, Peng SC, Wan ZQ, Yue ZB, Wu J, Chen TH Tags: Bioresour Technol Source Type: research

Genetic approaches to interfere with malaria transmission by vector mosquitoes.
Abstract Malaria remains one of the most devastating diseases worldwide, causing over 1 million deaths every year. The most vulnerable stages of Plasmodium development in the vector mosquito occur in the midgut lumen, making the midgut a prime target for intervention. Mosquito transgenesis and paratransgenesis are two novel strategies that aim at rendering the vector incapable of sustaining Plasmodium development. Mosquito transgenesis involves direct genetic engineering of the mosquito itself for delivery of anti-Plasmodium effector molecules. Conversely, paratransgenesis involves the genetic modification of mosqu...
Source: Trends in Biotechnology - February 6, 2013 Category: Biotechnology Authors: Wang S, Jacobs-Lorena M Tags: Trends Biotechnol Source Type: research

Dynamic chromatin remodelling of ciliate macronuclear DNA as determined by an optimized chromatin immunoprecipitation (ChIP) method for Paramecium tetraurelia.
We report the detailed evaluation of crucial parameters for chromatin immunoprecipitation (ChIP) of macronuclear DNA in the unicellular eukaryote Paramecium tetraurelia. Optimized parameters include crosslinking conditions, chromatin sonication and antibody titration thus providing a detailed protocol for successful ChIP in P. tetraurelia. As this ciliate is bacterivorous and RNAi by feeding represents a powerful tool for analysis of gene function, we moreover determined the effects of ingested nucleic acids by food bacteria. Feasibility of our protocol is demonstrated by characterisation of chromatin remodelling at promot...
Source: Applied Microbiology and Biotechnology - February 6, 2013 Category: Microbiology Authors: Cheaib M, Simon M Tags: Appl Microbiol Biotechnol Source Type: research

Structural and biochemical characterisation of a NAD(+)-dependent alcohol dehydrogenase from Oenococcus oeni as a new model molecule for industrial biotechnology applications.
Abstract Alcohol dehydrogenases are highly diverse enzymes catalysing the interconversion of alcohols and aldehydes or ketones. Due to their versatile specificities, these biocatalysts are of great interest for industrial applications. The adh3-gene encoding a group III alcohol dehydrogenase was isolated from the gram-positive bacterium Oenococcus oeni and was characterised after expression in the heterologous host Escherichia coli. Adh3 has been identified by genome BLASTP analyses using the amino acid sequence of 1,3-propanediol dehydrogenase DhaT from Klebsiella pneumoniae and group III alcohol dehydrogenases wi...
Source: Applied Microbiology and Biotechnology - February 6, 2013 Category: Microbiology Authors: Elleuche S, Fodor K, Klippel B, von der Heyde A, Wilmanns M, Antranikian G Tags: Appl Microbiol Biotechnol Source Type: research

Display of active beta-glucosidase on the surface of Schizosaccharomyces pombe cells using novel anchor proteins.
Abstract Here, we demonstrate display of beta-glucosidase (BGL) on the surface of Schizosaccharomyces pombe cells using novel anchor proteins. A total of four candidate anchor proteins (SPBC21D10.06c, SPBC947.04, SPBC19C7.05, and SPBC359.04c) were selected from among almost all of S. pombe membrane proteins. The C-terminus of each anchor protein was genetically fused to the N-terminus of BGL, and the fusion protein was expressed using S. pombe as a host. The highest cell surface-associated BGL activity (107 U/10(5) cells was achieved with SPBC359.04c serving as the anchor, followed by SPBC947.04 (44 U/10(5) cells...
Source: Applied Microbiology and Biotechnology - February 6, 2013 Category: Microbiology Authors: Tanaka T, Matsumoto S, Yamada M, Yamada R, Matsuda F, Kondo A Tags: Appl Microbiol Biotechnol Source Type: research

Characterization of ribose-5-phosphate isomerase converting D-psicose to D-allose from Thermotoga lettingae TMO.
Abstract The gene coding for ribose-5-phosphate isomerase (Rpi) from Thermotoga lettingae TMO was cloned and expressed in E. coli. The recombinant enzyme was purified by Ni-affinity chromatography. It converted D-psicose to D-allose maximally at 75 °C and pH 8.0 with a 32 % conversion yield. The k (m), turnover number (k (cat)), and catalytic efficiency (k (cat) k (m) (-1) ) for substrate D-psicose were 64 mM, 6.98 min(-1) and 0.11 mM(-1) min(-1) respectively. PMID: 23386225 [PubMed - as supplied by publisher]
Source: Biotechnology Letters - February 6, 2013 Category: Biotechnology Authors: Feng Z, Mu W, Jiang B Tags: Biotechnol Lett Source Type: research

Production of sophorolipids with eicosapentaenoic acid and docosahexaenoic acid from Wickerhamiella domercqiae var. sophorolipid using fish oil as a hydrophobic carbon source.
Abstract Sophorolipids (SLs) were synthesized by Wickerhamiella domercqiae var. sophorolipid CGMCC 1576 grown on fish oil and glucose. They were purified using preparative HPLC and their structures were identified by MS/MS. The yields of total and lactonic SLs were 47 and 19 g l(-1) in shake-flasks when fish oil 4 % (v/v) was used with glucose in the medium. The composition of SL mixture contained more than 20 SL molecules. Several unconventional SL molecules with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) including zero-, mono- and di-acetylated acidic SLs with EPA and a di-acetylated acidic SL w...
Source: Biotechnology Letters - February 6, 2013 Category: Biotechnology Authors: Li H, Ma XJ, Wang S, Song X Tags: Biotechnol Lett Source Type: research

Evidence for grow-through penetration of 0.2-μm-pore-size filters by Serratia marcescens and Brevundimonas diminuta.
Abstract We find that both Brevundimonas diminuta and Serratia marcescens can grow through sterilizing grade filter membranes of different membrane polymer compositions. Although this passage does not occur on a consistent basis, generation of "grow-through positive" results indicate that grow-through can occur stochastically at basal levels. This observation argues that the following risk mitigation strategies during pharmaceutical aseptic processing are warranted: minimization of processing times, and monitoring, minimizing and characterizing pre-filter bioburden. PMID: 23385852 [PubMed - as supplied by publisher]
Source: Journal of Industrial Microbiology and Biotechnology - February 6, 2013 Category: Microbiology Authors: Kaushal S, Gervais B, Lute S, Eroraha A, Faustino P, Brorson K, Hussong D Tags: J Ind Microbiol Biotechnol Source Type: research

Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.
We describe the most widely used methods for the expression of recombinant proteins in the cytoplasm or periplasm of E. coli, as well as strategies for secreting the product to the growth medium. Recombinant expression in E. coli influences the cell physiology and triggers a stress response, which has to be considered in process development. Increased expression of a functional protein can be achieved by optimizing the gene, plasmid, host cell, and fermentation process. Relevant properties of two yeast expression systems, S. cerevisiae and P. pastoris, are summarized. Optimization of expression in S. cerevisiae has focused...
Source: Journal of Industrial Microbiology and Biotechnology - February 6, 2013 Category: Microbiology Authors: Berlec A, Strukelj B Tags: J Ind Microbiol Biotechnol Source Type: research

Dynamic strain scanning optimization: an efficient strain design strategy for balanced yield, titer, and productivity. DySScO strategy for strain design
Conclusion: Our study demonstrated that the DySScO strategy is a useful computational tool for designing microbial strains with balanced yield, titer, and productivity, and has potential applications in evaluating the economic performance of the design strains.
Source: BMC Biotechnology - Latest articles - February 6, 2013 Category: Biotechnology Authors: Kai ZhuangLaurence YangWilliam CluettRadhakrishnan Mahadevan Source Type: research

Spanish researchers design biomarkers for the detection of dengue and West Nile virus
(University of Granada) The spin-off of the University of Granada Rekom Biotech designs recombinant antigens useful for the identification of these two viral diseases, which affect millions of people worldwide.
Source: EurekAlert! - Medicine and Health - February 6, 2013 Category: Global & Universal Source Type: news

Bihar role model for the world in immunisation: Gates Foundation
Incidentally, India became polio-free last year, and barring stray cases in West Bengal, the country remained polio-free in the past one year.
Source: The Economic Times Healthcare and Biotech News - February 5, 2013 Category: Pharmaceuticals Source Type: news

3D-Printed Human Embryonic Stem Cells Created for First Time
Imagine if you could take living cells, load them into a printer, and squirt out a 3D tissue that could develop into a kidney or a heart. Scientists are one step closer to that reality, now that they have developed the first printer for embryonic human stem cells. [More]
Source: Scientific American - Official RSS Feed - February 5, 2013 Category: Science Tags: Health,Chemistry,Health,Technology,Pharmaceuticals,Everyday Science,Biotechnology,Biotechnology,Medical Technology,Biology,Society & Policy Source Type: research

‘Busy’ Acceleron juggles eight Phase 2 trials at once
Acceleron Pharma, a privately-held biopharmaceutical company in Cambridge developing protein therapeutics for cancer and orphan disease, has announced two Phase 2 studies of its drug candidate, dalantercept, bringing the total to eight the company has going on at once. “We’ve been busy,” said Steve Ertel, chief business officer for Acceleron. Compared to other biotechs, which focus on bringing one drug across the finish line, “we’ve made a concerted effort to do the exact opposite.” The…
Source: bizjournals.com Health Care:Hospitals headlines - February 5, 2013 Category: Hospital Management Authors: Don Seiffert Source Type: research

RT-PCR- and MALDI-TOF Mass Spectrometry-Based Identification and Discrimination of Isoforms Homologous to Pufferfish Saxitoxin- and Tetrodotoxin-Binding Protein in the Plasma of Non-Toxic Cultured Pufferfish (Takifugu rubripes).
Abstract Four genes of Takifugu rubripes, tentatively designated Tr1-Tr4, encoding homologs of pufferfish saxitoxin- and tetrodotoxin-binding protein, were identified by BLAST search and 3'-RACE. RT-PCR and MALDI-TOF mass spectrometry allowed the identification and discrimination of Tr isoforms from the non-toxically cultured specimens. The expression of Tr1 and Tr3 mRNAs exclusively in the liver and the presence of their products as 120-kDa plasma proteins were confirmed. PMID: 23343608 [PubMed - in process]
Source: Bioscience, Biotechnology, and Biochemistry - February 5, 2013 Category: Biochemistry Authors: Tatsuno R, Yamaguchi K, Takatani T, Arakawa O Tags: Biosci Biotechnol Biochem Source Type: research

Galapagos says GSK starting trials of its new drug
BRUSSELS (Reuters) - Belgian biotech company Galapagos said on Tuesday that its partner GlaxoSmithKline (GSK) planned to start Phase II studies into a drug candidate to treat two auto-immune disorders.
Source: Reuters: Health - February 5, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Study: Republicans in Congress better armed than Democrats
USA Today surveyed members of Congress and found that Republicans are much more likely to be gun owners than Democrats. The newspaper found 119 Republicans and 46 Democrats said they owned guns. Others in Congress either wouldn't say or didn't respond to the question. Among the Georgia delegation, Democrat U.S. Reps. Sanford Bishop and John Barrow indicated they are gun owners. Democrat Rep. David Scott said he is not a gun owner. Democrat Reps. Hank Johnson, and John Lewis declined to answer. Republican…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Source Type: research

Are Drugs for Ultra-Rare Diseases the Future of Biotech? Francois Nader of NPS Weighs In
Over the last ten years, the global pharmaceutical industry has undergone dramatic changes. In the 1990s, big drug companies made hundreds of billions of dollars selling slightly improved versions of their competitors’ drugs; think of the epic battle between cholesterol-lowering drugs Lipitor and Zocor. Since then, however, an entirely new business model has emerged: developing drugs for rare, or “orphan” diseases, which are far easier to get through the FDA, and for which companies can charge significantly higher prices. The latest entry into the field is NPS Pharmaceuticals’ Gattex, which was approved last Decemb...
Source: Forbes.com Healthcare News - February 5, 2013 Category: Pharmaceuticals Authors: Avik Roy Source Type: news

Carroll Hospital Center moves forward on $28M renovation
Carroll Hospital Center is breaking ground on a $28 million renovation and addition to its Dixon building. The project calls for a 43,000-square-foot addition, for a total building size of 68,500 square feet. The building will house the Westminster hospital’s new William E. Kahlert Regional Cancer Center and the Tevis Center for Wellness. The project is largely being supported by the hospital center’s $22 million fund-raising campaign, “Campaign to Cure & Comfort, Always.” About $12 million…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Authors: Sarah Gantz Source Type: research

HCA earnings drop
HCA Holdings Inc. reported net income of $1.6 billion, or $3.49 a share, for 2012, compared to $2.5 billion, or $4.97 a share, in 2011. Revenue for 2012 totaled $33 billion, compared to $29.7 billion in 2011, a statement said. For the fourth quarter of 2012, HCA reported net income of $427 million, or 68 cents a share, on revenue of $8.43 billion. That was a 79 percent drop from the same quarter in 2011, according to a report in the Nashville Business Journal. HCA headquartered in Nashville, operates…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Source Type: research

Ohio Medicaid expansion would add 275K to rolls
Ohio Gov. John Kasich's move to expand the state’s Medicaid program would add 275,000 Ohioans to the program’s rolls. Ohio now joins 18 other states and Washington, D.C., that have committed to expansion. Expansion of Medicaid, which provides health coverage to low-income and disabled residents, is a key component of health care reform. But a summer U.S. Supreme Court ruling left states with the option to make any changes to their programs. Kasich, a Republican and no fan of the reform bill,…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Authors: James Ritchie Source Type: research

Forbes Health Summit: How Patient Groups Are Changing Biotech
This is one of a series of posts that presents, nearly in its entirety, the first annual Forbes Healthcare Summit that was held on December 5, 2012, in the Allen Room at Jazz at Lincoln Center in Manhattan. Two hundred and thirty-two executives, entrepreneurs, thinkers and policy makers gathered to talk, trade ideas, and grapple with a big-picture conversation about the health care system. Video of almost every single panel is included.
Source: Forbes.com Healthcare News - February 5, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

UB investing in multiple research efforts
Five University at Buffalo inventors or research teams have been awarded funds aimed at commercializing their innovations. In total, $213,762 was awarded from UB’s Catalyst Fund, which will enable researchers to conduct studies and other projects to demonstrate the commercial value of their potential products, according to the university. The Catalyst Fund was established in 2011 and has now disbursed about $450,000 total. “By providing for the translation of UB research that could lead to…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Authors: Dan Miner Source Type: research

Congressman Bera opens office in Rancho Cordova
Congressman Ami Bera opened his district office in Rancho Cordova on Monday and plans an open house for the public on Feb. 23. A doctor, a former University of California Davis professor and past medical director for primary health services in Sacramento County, Bera was elected Nov. 6 to represent Sacramento County in the U.S. House of Representatives. A Democrat, Bera replaced longtime Republican Congressman Dan Lungren. Bera’s district office is located at 11070 White Rock Road, Suite 195. A…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Authors: Kathy Robertson Source Type: research

UC student insurance may see hefty premium hike
University of California students, including those studying at University of California Davis, may face hefty health insurance premium hikes, according to the Daily Californian. The UC health insurance plan expects a $57 million deficit, and premiums are recommended to be raised by an average of 25 percent. That might mean students may opt out of the plan, leaving them vulnerable when it comes to medical emergencies.
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Source Type: research

A Hacked Database Prompts Debate about Genetic Privacy
Linking a human genome in an anonymous sequencing database to its real-world counterpart wasn’t supposed to be possible. [More]
Source: Scientific American Topic - Biotechnology - February 5, 2013 Category: Biotechnology Tags: Health,Chemistry,Health,Medical Technology,More Science,Biotechnology,Biotechnology,Biology,Technology Source Type: news

Why investors should track Raleigh’s Dara BioSciences
Investors could find profits with “near-term catalysts” from Dara BioSciences (Nasdaq: DARA). That’s according to a Seeking Alpha blog that points to the Raleigh-based oncology research firm as a company to watch. Dara shares, which traded at 80 cents Jan. 18, closed Monday at $1.11. The report notes that the stock is “up almost 39 percent in less than a month,” pointing out that an orphan-drug application for peripheral neuropathy and the exclusivity it could bring could make the firm…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Authors: Lauren K. Ohnesorge Source Type: research

Earnings: HCA down 79% in 4Q
HCA Holdings Inc.'s earnings were down 79 percent in the fourth quarter compared to the same period a year ago, according to the company's latest earnings report. HCA (NYSE: HCA) reported net income of $427 million, or 68 cents per share, on revenue of $8.43 billion. Analysts, on average, had estimated earnings of 82 cents per share on revenue of $8.9 billion, according to Thomson Reuters, the Nashville Business Journal reports. The company attributed the lower fourth-quarter earnings to legal…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Authors: E.J. Boyer Source Type: research

WellCare expands in Florida
The Florida Agency for Health Care Administration agreed to allow WellCare of Florida to expand its Staywell Medicaid managed care services. The expansion adds 25 new counties to the company’s service area and positions WellCare as the only Medicaid managed care provider offering plans in all 67 Florida counties, a statement said. “We serve more Florida Medicaid members than any other health plan,” said Chrissie Cooper, president of WellCare’s Florida and Hawaii division, in the statement. An…
Source: bizjournals.com Health Care:Biotechnology headlines - February 5, 2013 Category: Biotechnology Authors: Margie Manning Source Type: research